Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-023486

Options or other derivatives

  • CEO acquired 0 shares (option exercise)
  • CEO acquired 22,651 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-15 Exercise or conversion : show line 1 in the form 8% Unsecured Convertible Promissory Note −0 D
2026-05-15 Exercise or conversion : show line 2 in the form Series D-1 Convertible Preferred Stock +22,651 2,815,760 D
Loading xslF345X06/ownership.xml…